AHR financial statements
The full income statement, balance sheet, and cash-flow statement for American Healthcare REIT Inc. (AHR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.26B+9.1% | 2.07B+24.1% | 1.67B+18.2% | 1.41B+25.6% | 1.12B+5.1% | ||
| Lease income | 166M-11.4% | 187M-1.9% | 190M-7.3% | 205M+45.3% | 141M+17.8% | |
| Cost of revenue | 1.79B+8.4% | 1.65B+10.1% | 1.50B+17.2% | 1.28B+24.4% | 1.03B+3.7% | |
| Selling, general & administrative | 58.7M+23.5% | 47.6M+0.1% | 47.5M+9.4% | 43.4M+0.5% | 43.2M+60.0% | |
| General & administrative | 58.7M+23.5% | 47.6M+0.1% | 47.5M+9.4% | 43.4M+0.5% | 43.2M+60.0% | |
| Amortization of intangibles | 30.3M+8.5% | 28.0M-40.0% | 46.6M+64.2% | 28.4M+26.3% | 22.5M+236.3% | |
| Operating income | 415M+14.2% | 364M+18.5% | 307M+1.6% | 302M+41.5% | 213M-2.3% | |
| Interest expense | 85.8M-32.8% | 128M-21.7% | 163M+54.0% | 106M+30.9% | 80.9M+13.6% | |
| Other non-operating income | -115M+29.6% | -164M-11.1% | -147M+7.5% | -159M-108.6% | -76.2M+11.7% | |
| Equity-method income | -1.97M+71.4% | -6.87M-299.8% | -1.72M-222.1% | 1.41M+203.8% | -1.35M+70.0% | |
| Pre-tax income | 48.6M+243.6% | -33.9M+55.5% | -76.2M-4.7% | -72.8M-39.2% | -52.3M-1004.3% | |
| Income tax | -22.2M-1394.3% | 1.71M+158.4% | 663K+13.1% | 586K-38.7% | 956K+131.1% | |
| 69.8M+284.6% | -37.8M+47.1% | -71.5M+12.1% | -81.3M-70.1% | -47.8M-2309.6% | ||
| Net income to non-controlling interest | 1.01M-54.2% | 2.21M+140.8% | -5.42M-168.4% | 7.92M+244.6% | -5.47M-181.7% | |
| $0.42+244.8% | -$0.29+73.1% | -$1.08+12.9% | -$1.24-30.5% | -$0.95-2000.0% | ||
| EPS (basic) | $0.42+244.8% | -$0.29+73.1% | -$1.08+12.9% | -$1.24-30.5% | -$0.95-2000.0% | |
| Weighted-avg shares (basic) | 166M+27.1% | 131M+97.8% | 66.0M+0.4% | 65.8M+31.4% | 50.1M+11.3% | |
| Weighted-avg shares (diluted) | 167M+27.7% | 131M+97.8% | 66.0M+0.4% | 65.8M+31.4% | 50.1M+11.3% | |
| Dividends per share | $1.00+0.0% | $1.00+0.0% | $1.00-37.5% | $1.60+131.9% | $0.69-19.8% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash & equivalents | 115M+49.7% | 76.7M+76.5% | 43.4M-33.2% | 65.1M-20.3% | 81.6M-27.9% | |
| Inventory | 18.8M-3.3% | 19.5M+0.0% | 19.5M-1.5% | 19.8M+4.5% | 18.9M-23.3% | |
| 5.43B+20.9% | 4.49B-2.0% | 4.58B-4.4% | 4.79B+4.5% | 4.58B+41.6% | ||
| Operating lease right-of-use | 135M-17.4% | 164M-28.0% | 228M-17.5% | 276M+74.7% | 158M-22.5% | |
| Goodwill | 235M+0.0% | 235M+6953.2% | 3.33M-98.6% | 232M+10.3% | 210M+178.7% | |
| Intangible assets | 253M+56.8% | 161M-10.5% | 180M-23.6% | 236M-5.1% | 249M+60.9% | |
| 2.07B-5.4% | 2.18B-30.0% | 3.12B-0.6% | 3.14B+14.1% | 2.75B+27.3% | ||
| Operating lease liability (total) | 136M-17.9% | 165M-26.7% | 226M-17.4% | 273M+87.7% | 145M-24.9% | |
| Finance lease liability (total) | 33.9M+24289.9% | 139K+39.0% | 100K-33.3% | 150K+1.4% | 148K | |
| Deferred tax liabilities | 17.9M+22.2% | 14.6M-5.6% | 15.5M-4.9% | 16.3M-22.9% | 21.2M+7.3% | |
| 3.32B+46.9% | 2.26B+78.0% | 1.27B-9.3% | 1.40B-11.5% | 1.58B+82.6% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 4.88B+31.2% | 3.72B+46.0% | 2.55B+0.3% | 2.54B+0.3% | 2.53B+46.4% | |
| Retained earnings | -1.56B-6.9% | -1.46B-14.3% | -1.28B-12.1% | -1.14B-19.7% | -951M-10.1% | |
| Accumulated other comprehensive income | -2.10M+16.2% | -2.51M-3.6% | -2.42M+9.9% | -2.69M-36.8% | -1.97M+2.1% | |
| Non-controlling interest | 40.0M-6.4% | 42.7M-72.4% | 155M-7.6% | 168M-4.5% | 176M+4.3% | |
| Total equity incl. non-controlling | 3.36B+45.9% | 2.30B+61.6% | 1.43B-9.1% | 1.57B-10.8% | 1.76B+69.8% | |
| Total liabilities & equity | 5.43B+20.9% | 4.49B-2.0% | 4.58B-4.4% | 4.79B+4.5% | 4.58B+41.6% | |
| Common shares issued | 186M | — | — | — | — | |
| Common shares outstanding | 186M | — | — | — | — | |
| Shares outstanding (cover) | 188M+19.3% | 158M+141.0% | 65.4M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 294M+67.2% | 176M+78.7% | 98.5M-33.3% | 148M+724.9% | 17.9M-91.8% | ||
| Depreciation & amortization | 188M+4.7% | 179M-1.9% | 183M+8.7% | 168M+26.1% | 133M+34.7% | |
| Intangible amortization | 30.3M+8.5% | 28.0M-40.0% | 46.6M+64.2% | 28.4M+26.3% | 22.5M+236.3% | |
| Share-based compensation | 14.6M+48.1% | 9.87M+80.5% | 5.47M | — | 8.80M+755.8% | |
| Deferred income taxes | -22.9M | 0.00 | 0.00 | 0.00 | 0.00+100.0% | |
| -1.08B-12303.2% | -8.73M-193.0% | 9.40M+107.9% | -119M+14.5% | -139M+6.3% | ||
| Capital expenditure | 884M+1365.4% | 60.4M+33.0% | 45.4M+501.6% | 7.54M | — | |
| Free cash flow | -590M-609.8% | 116M+117.7% | 53.2M-62.1% | 140M | — | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 817M+706.5% | -135M-4.4% | -129M-200.7% | -42.9M-145.6% | 94.1M+1168.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 1.16B-15.2% | 1.36B | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00-100.0% | 14.0K-97.0% | 469K-97.7% | 20.7M+5318.6% | 382K-98.3% | |
| Dividends paid | 164M+35.3% | 121M+58.5% | 76.3M+49.2% | 51.1M+124.3% | 22.8M-15.6% | |
| FX effect on cash | 62.0K+168.1% | -91.0K-1400.0% | 7.00K-95.5% | 154K+308.1% | -74.0K+17.8% | |
| Interest paid | 80.1M-31.1% | 116M-23.8% | 153M+72.2% | 88.7M+26.3% | 70.2M+6.8% | |
| Income taxes paid | 1.80M+36.3% | 1.32M+1.8% | 1.30M+14.7% | 1.13M-8.7% | 1.24M+64.5% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 8.85B+97.6% | 4.48B | — | — | — | |
| P/E | 126.8× | — | — | — | — | |
| P/S | 3.9×+81.0% | 2.2× | — | — | — | |
| P/B | 2.7×+34.6% | 2.0× | — | — | — | |
| P/FCF | — | 38.7× | — | — | — | |
| Earnings yield | 0.79% | — | — | — | — | |
| FCF yield | — | 2.6% | — | — | — | |
| Dividend yield | 2.1%-39.6% | 3.5% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: AHR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AHR filings on SEC EDGAR → Not investment advice.
